한글목차

맞춤형 정신의학 시장은 2025년에는 50억 8,000만 달러, 2032년에는 107억 5,000만 달러에 이르고, 2025-2032년 연평균 복합 성장률(CAGR)은 11.3%를 나타낼 전망입니다.

맞춤형 정신의학은 정신질환의 진단 및 치료 방법의 변화를 목표로 하는 정신보건 분야의 새로운 분야입니다. 기존 정신의학은 환자가 광범위한 진단 기준에 따라 약물과 치료법을 처방받는 획일적인 접근 방식에 의존해 왔습니다. 맞춤형 정신의학은 환자 개개인에 특화된 유전학적, 생물학적, 임상적 데이터를 사용하여 정신건강에 특화된 치료와 요법을 만들어 냅니다. 맞춤형 정신의학은 획일적인 전략을 보다 집중적이고 맞춤화된 전략으로 대체하는 것을 목표로 합니다. 주요 기술로는 웨어러블 바이오센서, 컴퓨터화된 치료 프로그램, 정량적 뇌파, 약리유전체 검사, 분자진단 등이 있습니다. 정신 건강 문제에 대한 사회적 인식 증가, 신경 생물학 및 유전체 과학의 발전, 더 나은 정신 건강 진단 및 치료 결과의 필요성이 시장을 주도하는 주요 요인입니다.

시장 역학:

맞춤형 정신의학 시장은 디지털 헬스 기술의 급속한 발전, 유전체학, 웨어러블, 모바일 앱의 혁신 등 몇 가지 중요한 요인으로 인해 향후 몇 년 동안 큰 성장을 보일 것으로 예측됩니다. 또한, 정신 건강 평가 및 치료 분야의 인공지능은 예측 기간 동안 시장 성장을 가속할 것으로 예측됩니다. 이러한 기술은 실시간 데이터 수집을 가능하게 하여 임상의가 환자를 원격으로 모니터링하고 정보에 입각한 치료 결정을 내릴 수 있도록 돕습니다.

그러나 맞춤형 정신의학 시장은 몇 가지 과제에 직면해 있습니다. 주요 억제요인 중 하나는 개별화 접근법 도입에 따른 높은 비용입니다. 첨단 기술의 개발 및 도입에는 많은 비용이 소요되며, 이러한 서비스에 대한 상환 옵션도 제한적일 수 있습니다. 또한, 정신 건강 관리에서 유전자 및 디지털 데이터 활용을 둘러싼 규제 및 윤리적 문제도 개인화 접근법의 채택을 지연시킬 수 있습니다.

본 조사의 주요 특징

• 세계의 맞춤형 정신의학(Personalized Psychiatry) 시장을 상세하게 분석하여 2024년을 기준 연도로 하여 2025-2032년간 시장 규모와 연평균 성장률(CAGR)을 예측하여 전해드립니다.
• 또한, 다양한 부문에 걸친 잠재적 수익 기회를 밝히고, 이 시장의 매력적인 투자 제안 매트릭스를 설명합니다.
• 또한 시장 성장 촉진요인, 억제요인, 기회, 신제품 출시 및 승인, 시장 동향, 지역별 전망, 주요 기업의 경쟁 전략 등에 대한 중요한 고찰을 제공합니다.
• 이 보고서는 기업 하이라이트, 제품 포트폴리오, 주요 하이라이트, 재무 성과, 전략 등의 매개 변수를 기반으로 세계 개인화 정신의학 시장의 주요 기업을 프로파일링합니다.
• 이 보고서의 통찰력을 통해 마케팅 담당자와 기업 경영진은 향후 제품 출시, 유형화, 시장 확대, 마케팅 전술에 대한 정보에 입각한 의사결정을 내릴 수 있습니다.
• 세계 개인화 정신의학 시장 보고서는 투자자, 공급업체, 제품 제조업체, 유통업체, 신규 시장 진출기업, 재무 분석가 등 이 업계의 다양한 이해관계자를 대상으로 합니다.
• 이해관계자들은 세계 개인화 정신의학 시장 분석에 사용되는 다양한 전략 매트릭스를 통해 의사결정을 쉽게 내릴 수 있습니다.

목차

제1장 조사 목적과 전제조건

• 조사 목적
• 전제조건
• 약어

제2장 시장 전망

• 보고서 설명
  • 시장 정의와 범위
• 주요 요약
• Coherent Opportunity Map(COM)

제3장 시장 역학, 규제, 동향 분석

• 시장 역학
• 성장 억제요인
• 기회
• 영향 분석
• 주요 하이라이트
• 규제 시나리오
• 제품 발매/승인
• PEST 분석
• PORTER 분석
• 인수합병(M&A) 시나리오

제4장 맞춤형 정신의학 시장 - 코로나바이러스(COVID-19) 팬데믹의 영향

• COVID-19 역학
• 공급측과 수요측 분석
• 경제에 대한 영향

제5장 맞춤형 정신의학 시장 : 유형별, 2020년-2032년

• 제품
• 진단
• 치료제
• 서비스
• 소프트웨어

제6장 맞춤형 정신의학 시장 : 치료 분야별, 2020년-2032년

• 우울증
• 불안
• 조울증
• 정신분열증
• 중독
• 기타

제7장 맞춤형 정신의학 시장 : 지역별, 2020년-2032년

• 북미
  • 미국
  • 캐나다
• 라틴아메리카
  • 브라질
  • 멕시코
  • 아르헨티나
  • 기타 라틴아메리카
• 유럽
  • 영국
  • 독일
  • 이탈리아
  • 프랑스
  • 스페인
  • 러시아
  • 기타 유럽
• 아시아태평양
  • 중국
  • 인도
  • 일본
  • 호주
  • 한국
  • ASEAN
  • 기타 아시아태평양
• 중동
  • GCC
  • 이스라엘
  • 기타 중동
• 아프리카
  • 북아프리카
  • 중앙아프리카
  • 남아프리카

제8장 경쟁 구도

• GreyBird Ventures
• Sunovion Pharmaceuticals Inc.
• HBNC Holding GmbH
• Arcara Personalized Psychiatry
• Starling Minds
• Karuna Therapeutics
• CBT Plus
• AltheaDx, Inc.
• WayForward
• BrightQuest
• Peak Mental Wellness

제9장 섹션

• 조사 방법
• 출판사에 대해

영문목차

Personalized Psychiatry Market is estimated to be valued at USD 5.08 Bn in 2025 and is expected to reach USD 10.75 Bn by 2032, growing at a compound annual growth rate (CAGR) of 11.3% from 2025 to 2032.

Personalized psychiatry is an emerging field within the realm of mental healthcare that aims to revolutionize the way mental illnesses are diagnosed and treated. Traditionally, psychiatry has relied on a one-size-fits-all approach, where patients are prescribed medications or therapies based on broad diagnostic criteria. Using individual patient-specific genetic, biological, and clinical data, personalized psychiatry creates specialized mental health treatments and therapies. It seeks to replace the one-size-fits-all strategy with a more focused, customized one. Among the important technologies utilized are wearable biosensors, computerized therapy programs, quantitative EEG, pharmacogenomic testing, and molecular diagnostics. Growing public awareness of mental health issues, developments in neurobiology and genomics, and the need for better mental health diagnosis and treatment outcomes are the primary factors propelling the market.

Market Dynamics:

The personalized psychiatry market is expected to witness significant growth in the coming years, driven by several key factors such as rapid advancement of digital health technologies, innovations in genomics, wearables, and mobile apps. In addition, artificial intelligence in the field of mental health assessment and treatment is also expected to drive market growth over the forecast period. These technologies enable the collection of real-time data, allowing clinicians to monitor patients remotely and make informed decisions about their care.

However, the personalized psychiatry market also faces some challenges. One of the main restraints is the high cost associated with implementing personalized approaches. Developing and deploying advanced technologies can be expensive, and there may be limited reimbursement options for these services. Furthermore, there are regulatory and ethical considerations surrounding the use of genetic and digital data in mental healthcare, which may slow down the adoption of personalized approaches.

Key features of the study:

• This report provides in-depth analysis of the global personalized psychiatry market, and provides market size (US$ Bn) and compound annual growth rate (CAGR%) for the forecast period 2025-2032, considering 2024 as the base year
• It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
• This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
• It profiles key players in the global personalized psychiatry market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
• Key companies covered as a part of this study include GreyBird Ventures, Sunovion Pharmaceuticals Inc., HMNC Holding GmbH, Arcara Personalized Psychiatry, Starling Minds, Karuna Therapeutics, CBT Plus, AltheaDx, Inc., WayForward, BrightQuest, Peak Mental Wellness
• Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
• The global personalized psychiatry market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
• Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global personalized psychiatry market

Detailed Segmentation:

• By Type:
  • Products
  • Diagnostics
  • Therapeutics
  • Services
  • Software
• By Therapeutic Areas:
  • Depression
  • Anxiety
  • Bipolar Disorder
  • Schizophrenia
  • Addiction
  • Others
• By Region
  • North America
  • Latin America
  • Europe
  • Asia Pacific
  • Middle East
  • Africa
• Company Profiles
  • GreyBird Ventures
  • Sunovion Pharmaceuticals Inc.
  • HMNC Holding GmbH
  • Arcara Personalized Psychiatry
  • Starling Minds
  • Karuna Therapeutics
  • CBT Plus
  • AltheaDx, Inc.
  • WayForward
  • BrightQuest
  • Peak Mental Wellness

Table of Contents

1. Research Objectives and Assumptions

• Research Objectives
• Assumptions
• Abbreviations

2. Market Purview

• Report Description
  • Market Definition and Scope
• Executive Summary
  • Market Personalized Psychiatry, By Type
  • Market Personalized Psychiatry, By Therapeutic Areas
  • Market Personalized Psychiatry, By Region
• Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

• Market Dynamics
  • Growing need for improved diagnosis and treatment outcomes in mental healthcare
  • Rising prevalence of mental disorders
  • Growing adoption of precision medicine model in healthcare
• Restraints
• Opportunities
• Impact Analysis
• Key Highlights
• Regulatory Scenario
• Product launch/Approvals
• PEST Analysis
• PORTER's Analysis
• Merger and Acquisition Scenario

4. Personalized Psychiatry Market - Impact of Coronavirus (COVID-19) Pandemic

• COVID-19 Epidemiology
• Supply Side and Demand Side Analysis
• Economic Impact

5. Personalized Psychiatry Market, By Type, 2020-2032, (US$ Bn)

• Introduction
  • Market Share Analysis, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, 2021 - 2032
  • Segment Trends
• Products
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
• Diagnostics
• Therapeutics
• Services
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
• Software
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)

6. Personalized Psychiatry Market, By Therapeutic Areas, 2020-2032, (US$ Bn)

• Introduction
  • Market Share Analysis, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, 2021 - 2032
  • Segment Trends
• Depression
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
• Anxiety
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
• Bipolar Disorder
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
• Schizophrenia
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
• Addiction
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
• Others
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)

7. Personalized Psychiatry Market, By Region, 2020-2032, (US$ Bn)

• Introduction
  • Market Share Analysis, By Region, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, For Region, 2021 -2032
  • Country Trends
• North America
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Type, 2020-2032,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Therapeutic Areas, 2020-2032,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032,(US$ Bn)
    • U.S.
    • Canada
• Latin America
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Type, 2020-2032,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Therapeutic Areas, 2020-2032,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032,(US$ Bn)
    • Brazil
    • Mexico
    • Argentina
    • Rest of Latin America
• Europe
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Type, 2020-2032,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Therapeutic Areas, 2020-2032,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032,(US$ Bn)
    • U.K.
    • Germany
    • Italy
    • France
    • Spain
    • Russia
    • Rest of Europe
• Asia Pacific
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Type, 2020-2032,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Therapeutic Areas, 2020-2032,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032,(US$ Bn)
    • China
    • India
    • Japan
    • Australia
    • South Korea
    • ASEAN
    • Rest of Asia Pacific
• Middle East
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Type, 2020-2032,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Therapeutic Areas, 2020-2032,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032,(US$ Bn)
    • GCC
    • Israel
    • Rest of Middle East
• Africa
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Type, 2020-2032,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Therapeutic Areas, 2020-2032,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2020-2032,(US$ Bn)
    • North Africa
    • Central Africa
    • South Africa

8. Competitive Landscape

• GreyBird Ventures
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Sunovion Pharmaceuticals Inc.
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• HBNC Holding GmbH
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Arcara Personalized Psychiatry
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Starling Minds
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Karuna Therapeutics
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• CBT Plus
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• AltheaDx, Inc.
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• WayForward
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• BrightQuest
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Peak Mental Wellness
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Analyst Views

9. Section

• Research Methodology
• About us